Longevity Acquisition Corporation Pricing Their $40 Million SPAC Tonight
by Kristi Marvin on 2018-08-28 at 1:30pm

One Last SPAC to Close Out August and Bring the Month’s Deal Count to Seven.

To cap off a very busy August, Longevity Acquisition Corporation, filed their CERT today, indicating they will be pricing their IPO tonight for trading Wednesday (Nasdaq: LOACU).

Longevity, which will be focusing on companies in China, will be looking to raise $40 million at IPO.  However, there is always the possibility of an upsize given how attractive the China-focused SPAC structures are to investors.  Specifically, the terms provide 12 months to find an acquisition, but with three(3) 3-month extensions possible with an increase of $0.10 per share added to the trust for each extension.

The $40 million Longevity deal ends the SPAC-abundant summer on a high note.  To give some perspective on just how busy it actually was, in the past three months alone, (June, July, and August), there will be 16 deals, including Longevity, raising total gross proceeds of $3.772 billion. Looking at January through May, which has two extra months, only $3.354 billion was raised over 15 deals.

We have four more months left in the year.  Anybody want to start a pool on what we think final deal count and gross proceeds will be?

Cantor is sole bookrunning manager for Longevity Acquisition Corp.

Longevity Acquisition Corporation Summary of Terms:
  • Focus:  China
  • Size: $40 million
  • $10.00 unit comprised of one Ordinary Share + one Warrant (1/2 share) + one Right
  • Each Right entitles the holder to receive one-tenth (1/10) of one Share
  • Warrant call for redemption threshold: equals or exceeds $18.00 (cash or cashless exercise)
  • 100% held in trust ($10.00 per share)
  • Life: 12 months to complete an acquisition + three 3-month extensions ($0.10/share added to Trust for each extension)
  • Limitation on Redemption Rights: 15%
  • At-risk Capital: $2.7 million (270K private placement units, Cantor participating for 20K units)
  • Underwriter fees: 3.0% + 2.5% deferred. 

Cantor Fitzgerald is sole book-runner.

Ellenoff Grossman & Schole LLP and Loeb & Loeb LLP are Issuer’s Counsel and Underwriter’s Counsel, respectively.

 

Recent Posts
by Kristi Marvin on 2023-12-09 at 11:45am

Terms Tracker for the Week Ending December 8, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Well that escalated quickly. While last week was quiet, this week was far busier. SPACs saw one IPO start trading after pricing on Friday of...

by Marlena Haddad on 2023-12-08 at 1:59pm

Mobiv Acquisition Corp. (NASDAQ:MOBV) announced this afternoon that it has closed its combination with EV motorcycle-maker SRIVARU. Shareholders originally approved the deal at a special meeting held back on September 28, but at that time, the parties expected the transaction to take just a week to close. Redemptions whittled Mobiv’s IPO share pool of 10,005,000 down...

by Nicholas Alan Clayton on 2023-12-08 at 11:12am

Achari Ventures I (NASDAQ:AVHI) has entered into a definitive agreement to combine with medtech firm Vaso Corporation at an equity value of $176 million, or 19.5x its 2022 adjusted EBITDA. Wuxi, China-based Vaso provides IT services and sales support to medical device manufacturers. The combined company is expected to trade on the Nasdaq under the...

by Marlena Haddad on 2023-12-08 at 10:27am

EF Hutton Acquisition Corp. I (NASDAQ:EFHT) announced this morning that its shareholders have approved its business combination with E.C.D. Auto Design. At the meeting, there were 5,089,203 shares of common stock, representing approximately 76.82% of the issued and outstanding shares of common stock, present. In connection with the meeting, the company’s stockholders holding 3,470,945 shares,...

by Marlena Haddad on 2023-12-08 at 9:42am

Legato Merger Corp. III (NYSE:LEGT) filed for a $175 million IPO yesterday afternoon, becoming the fourth SPAC to file this week. While the other three SPACs that filed their S-1s earlier this week intend to pursue targets in the financial services and biotech industries, Legato III, similar to the earlier Legato SPACs, will focus on...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved